These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1495842)

  • 1. [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
    Le Gros V; Farinotti R; Brion N; Regnard JF; Azorin J; Parrot AM; Chiche D
    Pathol Biol (Paris); 1992 May; 40(5):545-50. PubMed ID: 1495842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats.
    ABO EL-SOOUD K; El-Banna HA; Hanafy MS; Goudah A
    Res Vet Sci; 2000 Dec; 69(3):219-24. PubMed ID: 11124092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery.
    Barbour A; Schmidt S; Rout WR; Ben-David K; Burkhardt O; Derendorf H
    Int J Antimicrob Agents; 2009 Sep; 34(3):231-5. PubMed ID: 19411164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic studies of cefuroxime in patients with liver cirrhosis.
    Okolicsanyi L; Venuti M; Orlando R; Xerri L; Pugina M
    Arzneimittelforschung; 1982; 32(7):777-82. PubMed ID: 6889880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative pharmacokinetics of 2 brands of cefuroxime following a single intramuscular injection.
    Irshaid YM; Rawashdeh NM; Zghol F; Jalal I; Najib NM
    Int J Clin Pharmacol Ther; 1995 May; 33(5):285-93. PubMed ID: 7655768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.
    Benchaoui HA; Nowakowski M; Sherington J; Rowan TG; Sunderland SJ
    J Vet Pharmacol Ther; 2004 Aug; 27(4):203-10. PubMed ID: 15305848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of cefuroxime and ceftazidime into human lungs.
    Perea EJ; Ayarra J; García Iglesias MC; García Luque I; Loscertales J
    Chemotherapy; 1988; 34(1):1-7. PubMed ID: 3280266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)].
    Adam D; Schalkhäuser K; Boettger F
    Med Klin; 1979 Dec; 74(49):1867-70. PubMed ID: 93238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and exacerbated chronic respiratory tract infections: treatment with a combination of cefuroxime and acetylcysteine.
    Dal Negro RW; Turco P; Zoccatelli O; Pomari C; Trevisan F
    Int J Clin Pharmacol Res; 1985; 5(5):345-50. PubMed ID: 4066085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levels of sulfametrole-trimethoprim in blood and lung-tissue during treatment of respiratory tract infection (author's transl)].
    Wieser O; Haiderer O; Takacs F
    Wien Med Wochenschr; 1981; 131(13-14):363-6. PubMed ID: 7281703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic availability of prophylactic cefuroxime in patients submitted to coronary artery bypass grafting with cardiopulmonary bypass.
    Nascimento JW; Carmona MJ; Strabelli TM; Auler JO; Santos SR
    J Hosp Infect; 2005 Apr; 59(4):299-303. PubMed ID: 15749317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Nickel Subsulfide (CAS No. 12035-72-2) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 453():1-365. PubMed ID: 12594522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefuroxime after intravenous, intramuscular, and subcutaneous administration to dogs.
    Albarellos GA; Montoya L; Lorenzini PM; Passini SM; Lupi MP; Landoni MF
    J Vet Pharmacol Ther; 2016 Feb; 39(1):40-4. PubMed ID: 25982523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori.
    Westblom TU; Duriex DE
    Microbiologica; 1991 Jan; 14(1):37-43. PubMed ID: 2067414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 451():1-381. PubMed ID: 12594524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
    Goudah A; Abo El Sooud K; Abd El-Aty AM
    Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery.
    Geroulanos S; Donfried B; Schumacher F; Turina M
    Drugs Exp Clin Res; 1985; 11(3):201-5. PubMed ID: 3915287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenous and intraperitoneal cefuroxime during peritoneal dialysis.
    La Greca G; Biasioli S; Chiaramonte S; Fabris A; Feriani M; Pisani E; Ronco C; Xerri L
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):92-4. PubMed ID: 7061184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.